一种缺陷工程双金属MOF纳米酶,具有增强的活性,用于对酸酸酶的色度检测
Hongbin Wu1, Jinbo Cao1, Xianglin Liao1
1Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, GDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, School of Chemistry, South China Normal University, Guangzhou, 510006, PR China.
Talanta
|December 10, 2025
概括
一种富含缺陷的新型金属有机框架纳米酶显示了对色度生物感知的增强活性. 这使得用于临床诊断的人体血清中检测酸酶 (ACP) 的敏感且具有成本效益的方法成为可能.
科学领域:
- 生物材料是一种生物材料.
- 纳米技术纳米技术
- 分析化学 分析化学
背景情况:
- 基于纳米酶的色度生物传感器提供了诸如简单性和成本效益等优势.
- 优化纳米酶结构对于增强催化活性和传感器效率至关重要.
研究的目的:
- 开发一种新的金属有机框架 (MOF) 纳米酶,具有类似缺陷的结构,以改善类似过氧化酶的活性.
- 使用开发的纳米酶建立一个灵敏和低成本的色度生物传感器,用于酸酶 (ACP) 检测.
主要方法:
- 合成了一种具有缺陷状结构的 His-MOF 纳米酶.
- 纳米酶的类似过氧化酶的活性使用3,3',5,5'-四甲丁 (TMB) -H2O2系统进行了评估.
- 基于ACP在TMB-H2O2反应中从L-酸-2-酸三盐 (AAP) 中产生的酸 (AA) 的抑制作用,开发了一种色度生物传感器.
主要成果:
- 该His-MOF纳米酶表现出显著增强的过氧化酶类活性.
- 开发的生物传感器显示了ACP的线性检测范围从0.2到7.0mU/mL,检测极限 (LOD) 为0.075mU/mL.
- 生物传感器成功地用于检测人类血清样本中的ACP活性.
结论:
- 富含缺陷的His-MOF纳米酶为色度生物感知提供了卓越的催化活性.
- 开发的ACP生物传感器具有高度灵敏性,具有成本效益,并适合临床诊断.
- 这种基于纳米酶的平台具有开发各种疾病超敏感诊断工具的潜力.
相关概念视频
Types of Toxins
3.6K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.6K
Toxic Reactions: Overview
4.1K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
379
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
379
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Bioactivation and Tissue Toxicity
151
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
151
Toxicity Testing in Animals
200
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
200


